Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Advanced Endometrial Cancer: Treatment Optimization : Episode 12

      Educating Patients With Endometrial Cancer on Treatment-Related Adverse Events

      January 6, 2023
      By Courtney R. Arn, APRN-CNP
      Kimberly Halla, NP
      • Kathleen Lutz, RN, NP-BC WH
      • Kimberly A. Spickes, CNP

      Commentary
      Video

      The panel explains how to educate patients on the adverse effects they may experience with chemotherapy, their options for management, and the importance of encouraging patients to contact their care team.

      EP: 1.Symptoms and Diagnosis of Endometrial Cancer

      EP: 2.Initial Consultation of Patients With Advanced Endometrial Cancer

      EP: 3.Conversations with Patients With Advanced Endometrial Cancer Before and After Diagnosis

      EP: 4.Resources for Patients With Endometrial Cancer

      EP: 5.Patient Profile Presentation: A 76-Year-Old Woman With Advanced Endometrial Cancer

      EP: 6.Fertility and Other Treatment Considerations for Patients With Advanced Endometrial Cancer

      EP: 7.Currently Available Treatment Modalities in Endometrial Cancer

      EP: 8.First-Line Treatments for Patients With Advanced Endometrial Cancer Who Are Unfit for Surgery

      EP: 9.Common Adverse Events Seen With Chemotherapy for Advanced Endometrial Cancer

      EP: 10.Efficacy of Chemotherapy in Patients with Advanced Endometrial Cancer

      EP: 11.Treatment Options for Patients with Recurrent Endometrial Cancer

      Now Viewing

      EP: 12.Educating Patients With Endometrial Cancer on Treatment-Related Adverse Events

      EP: 13.Monitoring Patients on Therapy for Recurrent Endometrial Cancer

      EP: 14.Adverse Events Seen With Combination Lenvatinib and Pembrolizumab for Recurrent Endometrial Cancer

      EP: 15.Proactive Adverse Effect Management for Patients on Therapy for Endometrial Cancer

      EP: 16.Discussing Dose Reductions and Interruptions with Patients on Therapy for Endometrial Cancer

      EP: 17.Greatest Unmet Needs for Patients with Endometrial Cancer

      EP: 18.Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Gynecologic Cancers
      Related Content

      Line illustration of a clipboard that says "FDA" with an approval mark in front on a cornflower blue background

      A Snapshot of April FDA Approvals in Oncology for Nurses and APPs

      Bridget Hoyt
      May 1st 2025
      Article

      Approvals in oncology during April included treatments for breast cancer, colorectal cancer, and more.


      The Vitals

      Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

      Lindsay Fischer
      June 15th 2023
      Podcast

      Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.


      Photo of a nurse holding a clipboard and talking to a patient

      Patient-Centered Communication Drives Supportive Care Needs in Incurable Cancer

      Kristie L. Kahl
      April 16th 2025
      Article

      The PRECURSOR intervention appeared feasible/acceptable, suggesting a need for patient-centered conversation in incurable gynecologic cancer treatment.


      Oncology Nursing News

      A Look Back at 2022 FDA Approvals in Oncology

      Oncology Nursing News
      January 2nd 2023
      Podcast

      In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.


      Line illustration of a clipboard that says "FDA"

      Bevacizumab Biosimilar Granted FDA Approval for Several Cancer Types

      Alex Biese
      April 10th 2025
      Article

      The FDA approved bevacizumab-nwgd across several gastrointestinal, gynecological, brain, and lung cancer types.


      Line illustration of the female reproductive system with a tumor in the uterine lining

      Opinion: Social Support is Key to Endometrial Cancer Recovery

      Amanda Brink, DNP, APRN, FNP-BC, AOCNP
      April 6th 2025
      Article

      Oncology nurses can enhance endometrial cancer recovery by fostering strong social support networks and improving communication with the patient.

      Related Content

      Line illustration of a clipboard that says "FDA" with an approval mark in front on a cornflower blue background

      A Snapshot of April FDA Approvals in Oncology for Nurses and APPs

      Bridget Hoyt
      May 1st 2025
      Article

      Approvals in oncology during April included treatments for breast cancer, colorectal cancer, and more.


      The Vitals

      Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

      Lindsay Fischer
      June 15th 2023
      Podcast

      Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.


      Photo of a nurse holding a clipboard and talking to a patient

      Patient-Centered Communication Drives Supportive Care Needs in Incurable Cancer

      Kristie L. Kahl
      April 16th 2025
      Article

      The PRECURSOR intervention appeared feasible/acceptable, suggesting a need for patient-centered conversation in incurable gynecologic cancer treatment.


      Oncology Nursing News

      A Look Back at 2022 FDA Approvals in Oncology

      Oncology Nursing News
      January 2nd 2023
      Podcast

      In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.


      Line illustration of a clipboard that says "FDA"

      Bevacizumab Biosimilar Granted FDA Approval for Several Cancer Types

      Alex Biese
      April 10th 2025
      Article

      The FDA approved bevacizumab-nwgd across several gastrointestinal, gynecological, brain, and lung cancer types.


      Line illustration of the female reproductive system with a tumor in the uterine lining

      Opinion: Social Support is Key to Endometrial Cancer Recovery

      Amanda Brink, DNP, APRN, FNP-BC, AOCNP
      April 6th 2025
      Article

      Oncology nurses can enhance endometrial cancer recovery by fostering strong social support networks and improving communication with the patient.

      Latest Conference Coverage

      Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R/R Myeloma

      Acupuncture Use in BC Predicted by Social Determinants of Health

      Variability Found in PROs, Gene Expression During AML Induction Chemo

      Blinatumomab-Linked ICANS Cases Higher Than Previously Reported

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.